Maze Therapeutics, Inc. (MAZE)
22.52
-0.92
(-3.92%)
USD |
NASDAQ |
Sep 18, 16:00
22.61
+0.09
(+0.40%)
After-Hours: 20:00
Maze Therapeutics Market Cap : 1.250B for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.250B |
| September 17, 2026 | 1.301B |
| September 16, 2026 | 1.327B |
| September 15, 2026 | 1.345B |
| September 14, 2026 | 1.369B |
| September 11, 2026 | 1.365B |
| September 10, 2026 | 1.378B |
| September 09, 2026 | 1.364B |
| September 08, 2026 | 1.464B |
| September 04, 2026 | 1.455B |
| September 03, 2026 | 1.436B |
| September 02, 2026 | 1.483B |
| September 01, 2026 | 1.473B |
| August 31, 2026 | 1.475B |
| August 28, 2026 | 1.523B |
| August 27, 2026 | 1.587B |
| August 26, 2026 | 1.642B |
| August 25, 2026 | 1.688B |
| August 24, 2026 | 1.643B |
| August 21, 2026 | 1.634B |
| August 20, 2026 | 1.606B |
| August 19, 2026 | 1.651B |
| August 18, 2026 | 1.617B |
| August 17, 2026 | 1.551B |
| August 14, 2026 | 1.509B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.536B |
| August 12, 2026 | 1.528B |
| August 11, 2026 | 1.516B |
| August 10, 2026 | 1.514B |
| August 07, 2026 | 1.590B |
| August 06, 2026 | 1.584B |
| August 05, 2026 | 1.383B |
| August 04, 2026 | 1.373B |
| August 03, 2026 | 1.359B |
| July 31, 2026 | 1.339B |
| July 30, 2026 | 1.374B |
| July 29, 2026 | 1.356B |
| July 28, 2026 | 1.387B |
| July 27, 2026 | 1.427B |
| July 24, 2026 | 1.377B |
| July 23, 2026 | 1.377B |
| July 22, 2026 | 1.417B |
| July 21, 2026 | 1.457B |
| July 20, 2026 | 1.411B |
| July 17, 2026 | 1.399B |
| July 16, 2026 | 1.351B |
| July 15, 2026 | 1.462B |
| July 14, 2026 | 1.486B |
| July 13, 2026 | 1.451B |
| July 10, 2026 | 1.520B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.749B |
| Corcept Therapeutics, Inc. | 11.90B |
| Veru, Inc. | 41.09M |
| Johnson & Johnson | 650.20B |
| Eli Lilly & Co. | 1.085T |
Market Cap Related Metrics
| PS Ratio | 59.20 |
| PEG Ratio | -0.1761 |
| Price to Book Value | 2.758 |
| Price | 22.52 |
| Earnings Yield | -11.25% |
| PEGY Ratio | -0.1761 |